Evidence map›Paper›PMID 41129153›Full record

ArticleJAMA network open2025

Community Factors and County-Level Cancer Screening, Prevalence, and Mortality.

Alexandra R Drake, Eric W Christensen, Augusto C Ochoa, William Small, Jinel Scott, Elizabeth Y Rula

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandra R DrakeHarvey L. Neiman Health Policy Institute, Reston, Virginia.
Eric W ChristensenHarvey L. Neiman Health Policy Institute, Reston, Virginia.
Augusto C OchoaDepartment of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans.
William SmallDepartment of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, Illinois.
Jinel ScottDepartment of Radiology, State University of New York Downstate Health Sciences University, Brooklyn.
Elizabeth Y RulaHarvey L. Neiman Health Policy Institute, Reston, Virginia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Cancer screening, prevalence, and mortality vary across US counties; the broad set of community factors associated with these differences are not well understood. Objective: To assess the relative importance of diverse community measures for explaining county-level variance in cancer screening, prevalence, and mortality rates for breast, colorectal, lung, and prostate cancers. Design, Setting, and Participants: This geospatial cross-sectional analysis across all US counties used random forest algorithms to estimate the relative importance of 24 community measures-including health behaviors and lifestyle, socioeconomic, and environment factors-as explanatory factors for cancer screening, prevalence, and mortality. For each cancer, county-level cancer screening and prevalence rates were based on a nationally representative 5% sample of Medicare fee-for-service beneficiaries (2020). The 5-year (2016-2020) mean mortality rates were from the National Cancer Institute's State Cancer Profiles. Neiman Cancer disparity maps geospatially display significant community-factor to cancer-outcome associations via county-level choropleth maps. Data were analyzed from September 2024 through February 2025. Exposure: Residence in the 50 states, Puerto Rico, and the District of Columbia. Main Outcomes and Measures: Outcomes were county-level rates of cancer screening, prevalence, and mortality for breast, colorectal, lung, and prostate cancers. Separate random forest algorithms estimated the relative importance of 24 community measures for each outcome-cancer type combination, and maps display county-level associations. Results: Among a nationally representative 5% of 2020 Medicare Fee-For-Service beneficiaries, 87% were aged 65 years or older. The top ranking explanatory community factors (100% relative importance) for mortality were smoking rate for both lung and colorectal cancers, and the non-Hispanic Black population share for both breast and prostate cancers. For prevalence and screening rates, the top factors were unique for each cancer type. Uninsured rate, unemployment, limited access to health foods, and poor physical health were the top ranked factors for breast, colorectal, lung, and prostate cancer prevalence, respectively. Hispanic population, poverty, air pollution, and Air Toxics Cancer Risk were ranked highest for screening rates, respectively, for each cancer. Two of only 3 environmental factors, Environmental Justice Index and Air Toxics Cancer Risk, had the most top-5 associations for mortality and screening, respectively. Uninsured rates for prevalence and poverty rates for screening were also important across cancer types. Conclusions and Relevance: In this cross-sectional study of the relative explanatory importance of community measures on cancer screening, prevalence, and mortality rate we found that the ranking of factors varied for each specific cancer and outcome, which can inform targeted population health efforts. Factors that ranked high across cancer types for a given outcome, such as uninsured rates for cancer prevalence, represent opportune targets for future study and broader policy change.

Indexed as

Early Detection of CancerNeoplasmsResidence CharacteristicsAgedBreast NeoplasmsColorectal NeoplasmsCross-Sectional StudiesFemaleHumansLung NeoplasmsMaleMedicarePrevalenceProstatic NeoplasmsSocioeconomic FactorsUnited States

Identifiers

PMID41129153
PMCPMC12550642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.